Safety Tolerability and Pharmacokinetic of BI 409306

NCT01343706 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo
DRUG: Placebo
DRUG: BI 409306
DRUG: BI 409306

Sponsor

Boehringer Ingelheim